PAVmed Inc. Annual report pursuant to Section 13 and 15(d)

Preferred Stock - Schedule of Estimated Fair Values for Series A-1 Convertible Preferred Stock Warrants (Details)

Preferred Stock - Schedule of Estimated Fair Values for Series A-1 Convertible Preferred Stock Warrants (Details)	12 Months Ended
	Dec. 31, 2018 USD ($) $ / shares shares
Series A-1 Convertible Preferred Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated fair value \| $	$ 189,550
Series A-1 Convertible Preferred Stock /Series A-1 Warrants \| shares	125,000
Value of common stock	$ 2.98
Common stock conversion factor numerator	4.00
Common stock conversion factor denominator	4.00
Exercise price per share - Series X Warrants
Required rate of return	27.00%
Series A-1 Convertible Preferred Stock [Member] \| Measurement Input, Expected Term [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	6 years 8 months 26 days
Series A-1 Convertible Preferred Stock [Member] \| Measurement Input, Price Volatility [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value assumptions, measurement input, percentages	52.00%
Series A-1 Convertible Preferred Stock [Member] \| Measurement Input, Risk Free Interest Rate [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value assumptions, measurement input, percentages	2.00%
Series A-1 Convertible Preferred Stock [Member] \| Measurement Input, Expected Dividend Rate [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value assumptions, measurement input, percentages	0.00%
Series A-1 Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated fair value \| $	$ 310,450
Series A-1 Convertible Preferred Stock /Series A-1 Warrants \| shares	125,000
Value of common stock	$ 2.98
Common stock conversion factor numerator
Common stock conversion factor denominator
Exercise price per share - Series X Warrants	$ 6.00
Required rate of return	0.00%
Series A-1 Warrants [Member] \| Measurement Input, Expected Term [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	6 years 8 months 26 days
Series A-1 Warrants [Member] \| Measurement Input, Price Volatility [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value assumptions, measurement input, percentages	52.00%
Series A-1 Warrants [Member] \| Measurement Input, Risk Free Interest Rate [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value assumptions, measurement input, percentages	2.00%
Series A-1 Warrants [Member] \| Measurement Input, Expected Dividend Rate [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value assumptions, measurement input, percentages	0.00%